A detailed history of Man Group PLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Man Group PLC holds 130,408 shares of BMRN stock, worth $8.69 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
130,408
Previous 85,046 53.34%
Holding current value
$8.69 Million
Previous $7.43 Million 44.55%
% of portfolio
0.03%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $3.38 Million - $4.18 Million
45,362 Added 53.34%
130,408 $10.7 Million
Q1 2024

May 15, 2024

BUY
$83.81 - $99.0 $1.74 Million - $2.05 Million
20,703 Added 32.18%
85,046 $7.43 Million
Q4 2023

Feb 14, 2024

SELL
$76.22 - $98.51 $2.21 Million - $2.86 Million
-29,049 Reduced 31.1%
64,343 $6.2 Million
Q3 2023

Nov 14, 2023

SELL
$85.07 - $94.48 $15.8 Million - $17.6 Million
-185,942 Reduced 66.57%
93,392 $8.26 Million
Q2 2023

Aug 14, 2023

SELL
$86.68 - $100.3 $39.1 Million - $45.3 Million
-451,312 Reduced 61.77%
279,334 $24.2 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $5.85 Million - $7.82 Million
66,677 Added 10.04%
730,646 $71 Million
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $9.34 Million - $12.5 Million
115,421 Added 21.04%
663,969 $68.7 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $31.6 Million - $37.2 Million
384,258 Added 233.89%
548,548 $46.5 Million
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $7.11 Million - $8.64 Million
99,513 Added 153.62%
164,290 $13.6 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $4.81 Million - $6 Million
64,777 New
64,777 $5 Million
Q4 2021

Feb 14, 2022

SELL
$71.72 - $91.47 $771,994 - $984,583
-10,764 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $412,356 - $471,367
-5,515 Reduced 33.88%
10,764 $832,000
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $3.59 Million - $4.03 Million
-47,504 Reduced 74.48%
16,279 $1.36 Million
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $1.34 Million - $1.62 Million
17,868 Added 38.92%
63,783 $4.82 Million
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $47,632 - $59,171
656 Added 1.45%
45,915 $4.03 Million
Q3 2020

Nov 16, 2020

SELL
$71.87 - $131.03 $3.46 Million - $6.31 Million
-48,177 Reduced 51.56%
45,259 $3.44 Million
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $5.16 Million - $8.05 Million
64,813 Added 226.44%
93,436 $11.5 Million
Q1 2020

May 15, 2020

SELL
$71.37 - $96.85 $976,127 - $1.32 Million
-13,677 Reduced 32.33%
28,623 $2.42 Million
Q4 2019

Feb 18, 2020

BUY
$64.27 - $86.37 $222,374 - $298,840
3,460 Added 8.91%
42,300 $3.58 Million
Q3 2019

Nov 14, 2019

BUY
$67.4 - $85.11 $102,582 - $129,537
1,522 Added 4.08%
38,840 $2.62 Million
Q2 2019

Aug 14, 2019

SELL
$80.35 - $93.9 $485,072 - $566,874
-6,037 Reduced 13.92%
37,318 $3.2 Million
Q1 2019

May 15, 2019

SELL
$84.2 - $98.62 $2.67 Million - $3.13 Million
-31,711 Reduced 42.24%
43,355 $3.85 Million
Q4 2018

Feb 14, 2019

SELL
$80.14 - $106.07 $1.13 Million - $1.5 Million
-14,116 Reduced 15.83%
75,066 $6.39 Million
Q3 2018

Nov 14, 2018

BUY
$93.92 - $105.72 $5.93 Million - $6.67 Million
63,109 Added 242.05%
89,182 $8.65 Million
Q2 2018

Aug 14, 2018

SELL
$76.01 - $99.03 $6.93 Million - $9.02 Million
-91,113 Reduced 77.75%
26,073 $2.46 Million
Q1 2018

May 15, 2018

BUY
$77.67 - $92.63 $9.1 Million - $10.9 Million
117,186 New
117,186 $9.5 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.